Bo Zhang
Visiting researcher at Institutionen för läkemedelskemi; Translationell avbildning med PET
- E-mail:
- bo.zhang@ilk.uu.se
- Visiting address:
- Dag Hammarskjöldsv 14C, 3tr
- Postal address:
- Dag Hammarskjöldsv 14C, 3tr
751 83 Uppsala
- ORCID:
- 0000-0002-9199-1115
More information is available to staff who log in.
Short presentation
My research mainly focuses on the developing of new F18 radiotracers and new methods of F18 radiolabelling
Keywords
- f18
- pet
- radiolabelling
- radiotracers
Publications
Recent publications
- [18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44 (2023)
- Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells. (2023)
- Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β (2023)
- PET Imaging of GPR44 by Antagonist [C-11]MK-7246 in Pigs (2021)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
All publications
Articles
- [18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44 (2023)
- Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells. (2023)
- Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β (2023)
- PET Imaging of GPR44 by Antagonist [C-11]MK-7246 in Pigs (2021)
- Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69 (2021)
- Lead compound identification from first-in-class high affinity Affibody molecules binders towards DGCR2
- Preclinical evaluation of Affibody molecule 18F-TZ-ZAM106 for PET imaging of DGCR2
- Positron Emission Tomography imaging of CD69 in a murine model of rheumatoid arthritis
